These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients. Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918 [TBL] [Abstract][Full Text] [Related]
3. Outcome of hepatitis B and C virus infection on graft function after renal transplantation. Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299 [TBL] [Abstract][Full Text] [Related]
4. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336 [TBL] [Abstract][Full Text] [Related]
5. The influence of hepatitis B infection on the outcome of renal allotransplantation. Flagg GL; Silberman H; Takamoto SK; Berne TV Transplant Proc; 1987 Feb; 19(1 Pt 3):2155-8. PubMed ID: 3547916 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus infection in allogeneic bone marrow transplantation. Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and renal transplantation. Scott D; Mijch A; Lucas CR; Marshall V; Thomson N; Atkins R Transplant Proc; 1987 Feb; 19(1 Pt 3):2159-60. PubMed ID: 3274482 [TBL] [Abstract][Full Text] [Related]
8. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors. Sumethkul V; Ingsathit A; Jirasiritham S Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen. Ahn HJ; Kim MS; Kim YS; Kim SI; Huh KH; Ju MK; Ahn SH; Han KH J Med Virol; 2007 Nov; 79(11):1655-63. PubMed ID: 17854044 [TBL] [Abstract][Full Text] [Related]
10. Should liver transplantation be performed for patients with hepatitis B? Eason JD; Freeman RB; Rohrer RJ; Lewis WD; Jenkins R; Dienstag J; Cosimi AB Transplantation; 1994 Jun; 57(11):1588-93. PubMed ID: 8009592 [TBL] [Abstract][Full Text] [Related]
11. HBsAg as predictor of outcome in renal transplant patients. Ridruejo E; Brunet Mdel R; Cusumano A; Diaz C; Michel MD; Jost L; Jost L; Mando OG; Vilches A Medicina (B Aires); 2004; 64(5):429-32. PubMed ID: 15560544 [TBL] [Abstract][Full Text] [Related]
12. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience. Murakami R; Amada N; Sato T; Orii T; Kikuchi H; Haga I; Ohashi Y; Okazaki H Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154 [TBL] [Abstract][Full Text] [Related]
13. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series. Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306 [TBL] [Abstract][Full Text] [Related]
14. Impact of hepatitis B and C virus on kidney transplantation outcome. Mathurin P; Mouquet C; Poynard T; Sylla C; Benalia H; Fretz C; Thibault V; Cadranel JF; Bernard B; Opolon P; Coriat P; Bitker MO Hepatology; 1999 Jan; 29(1):257-63. PubMed ID: 9862875 [TBL] [Abstract][Full Text] [Related]
15. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome. Berber I; Aydin C; Yigit B; Turkmen F; Titiz IM; Altaca G Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070 [TBL] [Abstract][Full Text] [Related]
16. A study of hepatitis B surface antigen positive patients on haemodialysis and following transplantation. Bhaskaran S; Mani MK; Prakash KC J Assoc Physicians India; 1994 May; 42(5):363-5. PubMed ID: 7829432 [TBL] [Abstract][Full Text] [Related]
17. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage. Fabrizio F; Bunnapradist S; Martin P J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272 [TBL] [Abstract][Full Text] [Related]
18. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883 [TBL] [Abstract][Full Text] [Related]
19. Severe clinical course of de novo hepatitis B infection after liver transplantation. Crespo J; Fábrega E; Casafont F; Rivero M; Heras G; de la Peña J; de la Cruz F; Pons-Romero F Liver Transpl Surg; 1999 May; 5(3):175-83. PubMed ID: 10226107 [TBL] [Abstract][Full Text] [Related]
20. Kidney transplantation into an ileal conduit: a single center experience of 59 cases. Surange RS; Johnson RW; Tavakoli A; Parrott NR; Riad HN; Campbell BA; Augustine T J Urol; 2003 Nov; 170(5):1727-30. PubMed ID: 14532763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]